Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.
Inge M W VerberkRosalinde E SlotSander C J VerfaillieHans HeijstNiels D PrinsBart N M van BerckelPhilip ScheltensCharlotte E TeunissenWiesje M van der FlierPublished in: Annals of neurology (2018)
Plasma Abeta42/Abeta40 ratio has potential as a prescreener to identify Alzheimer pathological changes in cognitively normal individuals with SCD. Ann Neurol 2018;84:656-666.